Alexandra Kropotova

Alexandra Kropotova

Chief Tech/Sci/R&D Officer at SAB BIOTHERAPEUTICS, INC.

Net worth: 155 866 $ as of 30/05/2026

54 year
Health Technology
Consumer Services

Profile

Alexandra Kropotova is currently an Independent Director at iBio, Inc. since 2020 and Chief Medical Officer & Executive Vice President at SAB Biotherapeutics, Inc. since 2022.
Formerly, Dr. Kropotova worked at Pfizer Inc. from 2002 to 2007 as Director & Head-Global Clinical Respiratory, at Sanofi from 2007 to 2016 as Vice President-Strategy & Head-Strategic Planning, and at Teva Pharmaceuticals, Inc. from 2016 to 2022 as VP-Global Specialty Research & Development.
Education includes an MBA from Ohio University Graduate College and a doctorate from Pacific State Medical University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
23/03/2026 43,296 ( 0.06% ) 155 866 $ 30/05/2026
19/11/2025 0 ( -.--% ) - $ 30/05/2026

Alexandra Kropotova active positions

CompaniesPositionStart
IBIO, INC. Director/Board Member 13/10/2020
SAB BIOTHERAPEUTICS, INC. Chief Tech/Sci/R&D Officer 05/06/2022

Former positions of Alexandra Kropotova

CompaniesPositionEnd
Corporate Officer/Principal 31/05/2022
SANOFI Corporate Officer/Principal 31/12/2015
PFIZER INC. Director/Board Member 31/12/2006
See the detail of Alexandra Kropotova's experience

Training of Alexandra Kropotova

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

76

1st degree connections

6

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies6

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

  1. Stock Market
  2. Insiders
  3. Alexandra Kropotova
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!